{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:19:39Z","timestamp":1773922779188,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The\n            <jats:italic>in vitro<\/jats:italic>\n            activities of modithromycin against Gram-positive and -negative respiratory pathogens, including macrolide-resistant cocci with different resistance mechanisms, were compared with those of other macrolide and ketolide agents. MICs were determined by the broth microdilution method. All 595 test strains used in this study were isolated from Japanese medical facilities. The\n            <jats:italic>erm<\/jats:italic>\n            (ribosome methylase) and\/or\n            <jats:italic>mef<\/jats:italic>\n            (efflux pump) gene, which correlated with resistance to erythromycin as well as clarithromycin and azithromycin, was found in 81.8%, 21.3%, and 23.2% of\n            <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n            ,\n            <jats:italic>Streptococcus pyogenes<\/jats:italic>\n            , and methicillin-susceptible\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            (MSSA) strains, respectively. Modithromycin showed MIC\n            <jats:sub>90<\/jats:sub>\n            s of 0.125 \u03bcg\/ml against these three cocci, including macrolide-resistant strains. In particular, the MIC of modithromycin against\n            <jats:italic>ermB<\/jats:italic>\n            -carrying\n            <jats:italic>S. pyogenes<\/jats:italic>\n            was \u226532-fold lower than that of telithromycin. The activities of modithromycin as well as telithromycin were little affected by the presence of\n            <jats:italic>mefA<\/jats:italic>\n            or\n            <jats:italic>mefE<\/jats:italic>\n            in both streptococci. Against Gram-negative pathogens, modithromycin showed MIC\n            <jats:sub>90<\/jats:sub>\n            s of 0.5, 8, and 0.031 \u03bcg\/ml against\n            <jats:italic>Moraxella catarrhalis<\/jats:italic>\n            ,\n            <jats:italic>Haemophilus influenzae<\/jats:italic>\n            , and\n            <jats:italic>Legionella<\/jats:italic>\n            spp., respectively. The MICs of modithromycin against\n            <jats:italic>M. catarrhalis<\/jats:italic>\n            and\n            <jats:italic>H. influenzae<\/jats:italic>\n            were higher than those of telithromycin and azithromycin. However, modithromycin showed the most potent anti-\n            <jats:italic>Legionella<\/jats:italic>\n            activity among the macrolide and ketolide agents tested. These results suggested that the bicyclolide agent modithromycin is a novel class of macrolides with improved antibacterial activity against Gram-positive cocci, including telithromycin-resistant streptococci and intracellular Gram-negative bacteria of the\n            <jats:italic>Legionella<\/jats:italic>\n            species.\n          <\/jats:p>","DOI":"10.1128\/aac.01469-10","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T04:25:08Z","timestamp":1294719908000},"page":"1588-1593","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["<i>In Vitro<\/i>\n            Antibacterial Activity of Modithromycin, a Novel 6,11-Bridged Bicyclolide, against Respiratory Pathogens, Including Macrolide-Resistant Gram-Positive Cocci"],"prefix":"10.1128","volume":"55","author":[{"given":"Takafumi","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan"},{"name":"Medicinal Research Laboratories, Shionogi &amp; Co., Ltd., Toyonaka, Osaka 561-0825, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihiro","family":"Iwata","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Toho University Omori Hospital, Ota-ku, Tokyo 143-8541, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ota-ku, Tokyo 143-8540, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00057-06"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.8.1091"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf504"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00234-06"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.4.475"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050337"},{"key":"e_1_3_2_8_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006"},{"key":"e_1_3_2_9_2","unstructured":"Performance standards for antimicrobial susceptibility testing 2006"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2005.04863.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1106.050222"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.10.022"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2007.04.006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.8.4083-4091.2005"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2008.0806"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.1.48"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(07)70004-3"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/324626"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1062"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081593"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0102349"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.4.527"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.203-207.2001"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/mcpr.2000.0320"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki378"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01474-10"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.08.019"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.8.2699-2702.2003"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.2.267"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01153-06"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01469-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01469-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:28:11Z","timestamp":1645486091000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01469-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1128\/AAC.01469-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.01469-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"2010-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-12-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}